LAUSR

Nucleotide oligomerization domain (NOD) proteins are cytoplasmic receptors that play important roles in host innate immune responses to pathogens by recognizing self or non‐self‐molecules and have been implicated in many autoimmune diseases including Guillain–Barré syndrome (GBS). The current study investigated whether NOD polymorphisms (NOD1‐Glu266Lys, rs2075820, and NOD2‐ [Arg702Trp, rs2066844 and Gly908Arg, rs2066845]) contribute to ligand sensing and thus affect the susceptibility and/or severity of GBS.